Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CISPLATIN vs OXALIPLATIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CISPLATIN vs OXALIPLATIN: Safety Overview

Metric CISPLATIN OXALIPLATIN
Total FAERS Reports 47,481 56,406
Deaths Reported 8,387 6,501
Death Rate 17.7% 11.5%
Hospitalizations 17,469 21,980
Average Patient Age 52.7 yrs 61.5 yrs
% Female Patients 40.0% 42.1%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 28, 2011
Manufacturer Apotex Corp. Camber Pharmaceuticals, Inc.
Route INTRAVENOUS INTRAVENOUS
Marketing Status Discontinued Discontinued